News from Veracyte A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 19, 2016, 12:01 ET Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2016 Financial Results on Thursday, May 5, 2016

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its first quarter 2016 financial results after close of market on Thursday,...


Apr 02, 2016, 13:15 ET Clinical Utility of Veracyte's Afirma® Gene Expression Classifier Demonstrated in Multiple Studies Presented at ENDO 2016

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from two new...


Mar 29, 2016, 16:05 ET Multiple Studies Showcasing Clinical Utility of Veracyte's Afirma® Gene Expression Classifier to Be Presented at ENDO 2016

 Veracyte, Inc. (NASDAQ: VCYT) today announced that company and external researchers will deliver poster presentations demonstrating the...


Mar 28, 2016, 08:00 ET Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, and Visium Healthcare Partners, LP,...


Mar 22, 2016, 07:30 ET New Study Supports Use of Veracyte's Medullary Thyroid Cancer Classifier as Part of Its Comprehensive Afirma Solution

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data from a large,...


Mar 16, 2016, 07:30 ET New Data Show That Veracyte's Afirma® Gene Expression Classifier Reduces Unnecessary Thyroid Surgeries and Costs During Long-Term Follow-Up

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced publication of data...


Mar 10, 2016, 16:05 ET Veracyte Announces Fourth Quarter and Full-Year 2015 Financial Results, Provides 2016 Financial Outlook

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results and business progress for the quarter and full year ended December 31, 2015,...


Feb 29, 2016, 16:05 ET Veracyte Announces Publication of Data Confirming Analytical Verification of Percepta® Bronchial Genomic Classifier

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data confirming the...


Feb 25, 2016, 11:12 ET Veracyte Announces Publication of Data Supporting Clinical Utility of the Percepta® Bronchial Genomic Classifier in Lung Cancer Diagnosis

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data supporting the...


Feb 25, 2016, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2015 Financial Results on March 10

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its fourth quarter and full-year 2015 financial results after close of...


Feb 19, 2016, 07:30 ET Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that an independent...


Jan 28, 2016, 07:30 ET Veracyte Receives Regulatory Authorization to Offer Percepta™ Bronchial Genomic Classifier for Patients in New York State

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has...


Jan 27, 2016, 08:00 ET Veracyte to Participate in Two Upcoming Investor Conferences

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Leerink...


Jan 22, 2016, 07:30 ET Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma® Gene Expression Classifier

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data demonstrating...


Jan 07, 2016, 16:10 ET Veracyte Announces Expansion to New South San Francisco Facility

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that the company is...


Dec 21, 2015, 08:00 ET Veracyte to Present at the 34th Annual J.P. Morgan Healthcare Conference

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the 34th Annual...


Dec 14, 2015, 16:05 ET Veracyte Announces Positive Coverage Policy for the Afirma® Gene Expression Classifier from Health Care Service Corporation (HCSC)

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Health Care...


Nov 18, 2015, 08:00 ET Veracyte to Present at Piper Jaffray 27th Annual Healthcare Conference

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will participate in a fireside...


Nov 17, 2015, 19:00 ET Veracyte Applauds CMS Decision to Use "Gapfill" Pricing for the Afirma® Gene Expression Classifier

Veracyte, Inc. (NASDAQ: VCYT) issued a statement in response to the Centers for Medicare and Medicaid Services' (CMS) decision to use a "gapfill"...


Nov 16, 2015, 16:05 ET Veracyte Names Tina S. Nova, Ph.D. to Its Board of Directors

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Tina S. Nova,...


Nov 12, 2015, 17:15 ET Veracyte Announces New Data Supporting Advancement of Its IPF Program Presented Today at PFF Summit 2015

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that studies...


Nov 05, 2015, 16:05 ET Veracyte Announces Third Quarter 2015 Financial Results

 Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the third quarter ended September 30, 2015 and provided an update on...


Nov 04, 2015, 07:30 ET Veracyte Announces Data to be Presented at PFF Summit 2015 Highlighting IPF Diagnostic Challenges and Potential of New Genomic-Based Testing Approaches

Veracyte, Inc. (NASDAQ: VCYT) announced that company and external researchers will present four abstracts at the PFF Summit 2015: From Bench to...


Oct 29, 2015, 11:24 ET Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2015 Financial Results on Thursday, November 5, 2015

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced today that its third...


Oct 21, 2015, 09:20 ET Veracyte Presents New Data on Gene Variants and Fusions In Thyroid Cancer Diagnosis

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced findings from a new...